GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » 5-Year EBITDA Growth Rate

Omid Holdings (Omid Holdings) 5-Year EBITDA Growth Rate : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings 5-Year EBITDA Growth Rate?

Omid Holdings's EBITDA per Share for the three months ended in . 20 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Omid Holdings's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Omid Holdings's 5-Year EBITDA Growth Rate falls into.



Omid Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Omid Holdings  (OTCPK:OMID) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Omid Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Omid Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020

OMID Posts Second Quarter Financial Statements

By PRNewswire PRNewswire 08-10-2021

OMID Acquires Champ Life Brand

By PRNewswire PRNewswire 04-20-2021

OMID Holdings, Inc. Issues a Letter to Shareholders

By PRNewswire PRNewswire 02-26-2020

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

OMID Provides Third-Quarter Financial Results

By PRNewswire PRNewswire 10-16-2020

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Holdings, Inc. Issues Shareholder Letter

By PRNewswire PRNewswire 03-02-2021

OMID Announces Reduction of Common Shares

By PRNewswire PRNewswire 06-24-2021